The DNA damage checkpoint response delays cell cycle progression upon DNA damage and prevents genomic instability. Genetic analysis has identified sensor, mediator, signal transducer, and effector components of this global signal transduction pathway. Here we describe an in vitro system with purified human checkpoint proteins that recapitulates key elements of the DNA damage checkpoint. We show that the damage sensor ATR in the presence of topoisomerase II binding protein 1 (TopBP1) mediator/adaptor protein phosphorylates the Chk1 signal-transducing kinase in a reaction that is strongly dependent on the presence of DNA containing bulky base lesions. The dependence on damaged DNA requires DNA binding by TopBP1, and, indeed, TopBP1 shows preferential binding to damaged DNA. This in vitro system provides a useful platform for mechanistic studies of the human DNA damage checkpoint response.Chk1 kinase ͉ damage recognition ͉ signal transduction ͉ topoisomerase II binding protein 1 M ost of our knowledge about the DNA damage checkpoint response is based on genetic data from model organisms, including budding and fission yeasts and humans and the Xenopus egg extract system. These studies have identified damage sensors, mediators, signal transducers, and effectors as key components of this signal-transduction pathway (1-3). The phosphatidylinositol 3-kinase-related protein kinase (PIKK) family members have been shown to be key DNA damage sensors and signal transducers in the checkpoint response. Of these, ATM is mainly responsible for initiation of the checkpoint response elicited by double-strand breaks caused by ionizing radiation or radiomimetic agents. Some semidefined systems for the ATM-mediated checkpoint response have been described recently (4-8). Another PIKK family member, ATR, initiates the DNA damage checkpoint response caused by UV radiation and UV-mimetic agents that produce base damage such as N-acetoxy-2-acetylaminofluorene (N-Aco-AAF). Although this important signal-transduction pathway has been characterized in some detail by using Xenopus egg extracts (9-15) and in human cell-free systems (16, 17), only recently have partial in vitro systems been developed with a subset of either Xenopus (14, 15) or yeast (18) checkpoint proteins. Currently, there is no well defined system for ATR-mediated DNA damage checkpoint response in humans. Recently, it has been shown that the multifunctional XtopBP1 protein, which is known to be required for the ATR-mediated checkpoint (19), activates the ATR kinase on downstream targets, in particular the Chk1 signaltransducing kinase, in the absence of DNA or any other checkpoint protein except the ATR-interacting protein (ATRIP) (14). Here we describe a human in vitro system in which ATR phosphorylates Chk1 kinase in a reaction that depends on topoisomerase II binding protein 1 (TopBP1) and is strongly stimulated by DNA containing bulky DNA adducts. We believe this is a useful system for the ultimate development of an in vitro human checkpoint response dependent on all che...